Skip to main content

InvestorNewsBreaks – RYAH Group Inc. (CSE: RYAH) Releases Update on Status of Proprietary Smart Inhalers

RYAH Group (CSE: RYAH) has reported the status of its business progress. The update was released by new management, which noted that lack of information had been an issue; the new management team anticipates providing regular updates regarding the business. The initial update covers RYAH’s flagship product, the Smart Inhaler, arguably the best dry herb vaporizer on the market. The update includes a look at various clinical and scientific studies using the Smart Inhaler to deliver medical marijuana. According to the announcement, the Smart Inhaler’s convection heater vaporizes contents then ensure an even distribution; the patented mouthpiece enables the user to select the temperatures of the draw. The device is currently being used in the following trials: a United Kingdom trial that is studying the efficacy of cannabis for treating about 5,000 patients suffering from pain and will initially use an estimated 5,000 inhalers and 500,000 cartridges, and then substantially more when generally available through the NHS; a veterans trial in the United States that will use the Smart Inhalers to administer federally grown medical marijuana to US veterans nationwide for the treatment of post-traumatic stress disorder (“PTSD”); a COVID-19 trial held in the United states involving up to 11,000 participants and analyzing potential anti-inflammatory effects of cannabis for the prevention and treatment of COVID-19; and several European Union trials that are expected to use tens of thousands of inhalers and millions of cartridges for trials. In addition, the company noted that there are additional markets and studies that are pending approval, including Australia, New Zealand and Israel. The company also reported that a THC lab in Italy had conducted an investigation of the operational efficiency of the RYAH Smart Inhaler, which was successful; the lab is now using the RYAH Smart Inhaler in tests employing an artificial lung. “While absolutely pleased with our progress achieving medical device certifications, approvals and clinical trials leading to opening up various national health systems, we are also going to address the global mass market for wellness,” said RYAH CEO Dr. Dave Richards in the press release. “Although the medical market is huge, with millions of patients who will want RYAH Smart Inhalers provided by their health services or insurance, the market for wellness and recreational use of marijuana is even bigger. I consider recreational use an aspect of the wellness market, given that people use cannabis if it makes them feel good. Feeling good is wellness.”

To view the full press release, visit

About RYAH Group Inc.

RYAH is a big data and technology company enabling valuable AI-powered predictive analytics of the efficacy of plant-based medicines and other nutraceuticals administered through its range of innovative IoT-connected medical devices including inhalers, patches and pens. RYAH’s robust big data platform, the only one of its kind in this space, aggregates and analyzes HIPAA-compliant patient data, helping doctors and patients personalize treatments, control dosages, and better predict and monitor outcomes. Beyond specific medical uses, RYAH supports the use of a variety of nutraceuticals by users for wellness purposes, including personal enjoyment, i.e., recreational use. The collection and analyses of objective and subjective usage data, along with data derived through natural language processing of various scientific and other relevant literatures, will enable highly valuable insights for a wide variety of stakeholders, starting with the users themselves, and extending to clinicians, medical scientists, insurance providers, dispensaries, licensed growers, producers, pharmaceutical producers and more. Through the above, a relentless focus on innovation and track record of developing win-win collaborative partnerships within relevant industries, RYAH is continuously building a unique and highly valuable IP portfolio and big data assets ready to be monetized. For more information about the company, please visit

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.